KMK Kromek Group plc
Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets. It offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray and neutron detection. The company also provides advanced imaging products, including CZT gamma detectors for SPECT imaging, CZT bone mineral densitometry detectors, D-Matrix gamma ray imager, and photon-counting spectral CT systems. In addition, it offers products and components for the security and defense markets, including UAV radiation mapping drones, alpha beta probes, radiation detectors, gamma and neutron detectors, D5 RIID, backpack with radiation detection, static node, tactical deployment detector charging station, and vehicle mounted radiation detector, as well as a range of gamma spectroscopy software that enables specialized analysis of samples. Further, the company provides CZT imaging research development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array for laboratory and research imaging; and engages in scientific research and development activities. It sells its products through distributors, OEMs, and direct sales. The company was founded in 2003 and is headquartered in Sedgefield, the United Kingdom.…
Industry Peers
Scientific & Technical InstrumentsKey Statistics
About Kromek Group (LON: KMK)
›
Kromek Group (LON: KMK) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Scientific & Technical Instruments industry, part of the Technology sector, and reports about 166 employees.
The shares were at 5.500 GBp on 20 November 2026, down 22.5% over 52 weeks. Its 52-week range is 5.200 GBp to 13.00 GBp: the price is 57.7% below the high and 5.8% above the low.
Its market capitalisation is 36.04M GBP.
Kromek Group reports return on equity of 1.3%, an operating margin of 10.7% and revenue down 47.0% year over year.
Its debt exceeds its cash by 5.19M GBP, a debt-to-equity ratio of 0.17. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.